Generic Drug Bill Campaign to Resume New House Leans to Brand-Name Switches

By Pendleton, Randolph | The Florida Times Union, February 5, 2001 | Go to article overview

Generic Drug Bill Campaign to Resume New House Leans to Brand-Name Switches


Pendleton, Randolph, The Florida Times Union


TALLAHASSEE -- Brand-name pharmaceutical companies easily defeated legislative efforts last year to make it easier to substitute cheaper generic drugs for some of their products. So why should they be worried about the coming session?

Byron Thames, a doctor who is chairman of the Florida Coalition for Patient Safety, has a succinct answer.

"The new speaker is not John Thrasher," he said.

Thrasher, a former general counsel for the Florida Medical Association, was speaker of the House last year when the bill failed to make it to the floor for a vote.

But Thrasher is gone, a victim of term limits, and Tom Feeney, R-Oviedo, is the new House leader.

Although Feeney has not yet taken a position on the generic drug issue, one of his top lieutenants, House Republican Leader Mike Fasano of New Port Richey, is co-sponsoring the generic-substitution bill this year.

That could signal a change in attitude on the part of the House leadership.

It would be unusual for a member of the leadership team to be out front on an issue if the speaker were likely to be on the other side.

Kimberly Stone, a spokeswoman for Feeney, said the speaker will examine the economic and health effects of the legislation, and if both are positive, he would support it.

The bill gets its first test tomorrow in the House Health Regulation Committee.

Millions of dollars are at stake in this battle between the makers of the name-brand drugs and the generics.

Defenders of the current law, a so-called negative formulary that prohibits pharmacists from substituting generics for a list of 11 brand-name prescription drugs, say changing it would endanger the lives of patients.

But opponents of the restriction say financially strapped elders are forced to pay too much because they are denied the cheaper generics.

"We need to stop protecting the brand-name drugs and start protecting our senior citizens," said Rep. Nancy Argenziano, R-Dunnellon.

Argenziano, a co-sponsor of this year's bill, warned legislators to expect a flood of television ads by brand-name drug companies claiming that the generic drugs are risky.

Nonetheless, she appeared optimistic for the chances of the legislation.

"It really doesn't hurt at all to have the majority leader pushing the bill along," Argenziano said.

The bill would allow substitutions for five drugs the U.S. Food and Drug Administration has determined have generic equivalents. …

The rest of this article is only available to active members of Questia

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Generic Drug Bill Campaign to Resume New House Leans to Brand-Name Switches
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Help
Full screen

matching results for page

    Questia reader help

    How to highlight and cite specific passages

    1. Click or tap the first word you want to select.
    2. Click or tap the last word you want to select, and you’ll see everything in between get selected.
    3. You’ll then get a menu of options like creating a highlight or a citation from that passage of text.

    OK, got it!

    Cited passage

    Style
    Citations are available only to our active members.
    Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

    1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

    Cited passage

    Thanks for trying Questia!

    Please continue trying out our research tools, but please note, full functionality is available only to our active members.

    Your work will be lost once you leave this Web page.

    Buy instant access to save your work.

    Already a member? Log in now.

    Oops!

    An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.